Accuray Incorporated
ARAY

$
Marketcap
$0.00
Share price
Country
$0.04
Change (1 day)
$3.05
Year High
$1.40
Year Low

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

marketcap

Revenue of Accuray Incorporated (ARAY)

Revenue in 2024 (TTM): $446.55 M

According to Accuray Incorporated's latest financial reports the company's current revenue (TTM) is $446.55 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Accuray Incorporated

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2024 $446.55 M $142.92 M $5.71 M $-11,820,000 $-15,545,000
2023 $447.61 M $153.96 M $9.61 M $-6,788,000 $-9,280,000
2022 $429.91 M $159.96 M $13.66 M $-2,002,000 $-5,347,000
2021 $396.29 M $159.51 M $28.62 M $-4,559,000 $-6,311,000
2020 $382.93 M $149.87 M $20.08 M $5.02 M $3.83 M
2019 $418.79 M $162.65 M $11.07 M $-14,344,000 $-16,430,000
2018 $404.9 M $161.7 M $1.67 M $-23,021,000 $-23,899,000
2017 $383.41 M $141.34 M $6.8 M $-28,541,000 $-29,579,000
2016 $398.8 M $158.71 M $12.59 M $-23,168,000 $-25,504,000
2015 $379.8 M $145.4 M $-1,779,000 $-37,790,000 $-40,209,000
2014 $369.42 M $142.8 M $2.49 M $-32,360,000 $-35,448,000
2013 $315.97 M $97.64 M $-57,846,000 $-93,788,000 $-103,219,000
2012 $409.22 M $137.27 M $-35,455,000 $-75,858,000 $-72,042,000
2011 $222.28 M $107.24 M $-18,429,000 $-25,995,000 $-26,682,000
2010 $221.63 M $104.02 M $9.99 M $2.84 M $2.84 M
2009 $233.6 M $115.29 M $7.33 M $664 K $609 K
2008 $210.38 M $106.95 M $14.11 M $6.25 M $5.38 M
2007 $140.45 M $80.04 M $1.39 M $-5,010,000 $-5,616,000
2006 $52.9 M $25.41 M $-29,686,000 $-33,436,000 $-33,694,000
2005 $22.38 M $11.26 M $-22,803,000 $-25,121,000 $-25,189,000
2004 $19.57 M $19.57 M $19.57 M $ $-11,696,000
2003 $2.71 M $-317,000 $-15,886,000 $-15,840,000 $-15,840,000
2002 $19.35 M $19.35 M $19.35 M $-5,797,000 $